We describe a strategy aimed at maximizing the safety and minimizing the thrombogenicity of central venous lines for neonates with congenital heart defects. Our method involves the use of a tunneled technique to place a 4.2 Fr single-lumen (Broviac) catheter in the subpericardial space, with minimal intravascular course and a tip placed in the lower right atrium. Using this technique, we potentially eliminated the requirement for percutaneous placement of central venous lines postoperatively as well as potentially decreased the risk of intrapericardial bleeding associated with transthoracic lines.
Introduction
Central venous lines in infants undergoing congenital cardiac surgery play an important role in the perioperative period. Their use in fluid management, medication administration, and hemodynamic monitoring makes them a requirement for some, but complications associated with central venous lines in infants remain a costly and morbid challenge.
Central venous line-related deep vein thrombosis (DVT) is common in the pediatric population. More than 90% of DVT in neonates, and 60% in children, occurs in association with central venous lines (CVLs). 1 Central venous lines significantly contribute to morbidity as the commonest cause of pulmonary embolism in children and congenital heart disease may further increase the risk of DVT-associated adverse events. 2 For patients with intracardiac communications, such systemic venous thromboembolic events produce a high risk of systemic embolization, stroke, or other end-organ ischemia.
Taking into consideration the known elements that contribute to CVL-related DVT, we designed a strategy aimed at maximizing the safety and minimizing the thrombogenicity of CVLs for the at-risk population of neonates with congenital heart defects. A tunneled, single-lumen silastic catheter, with minimal length exposed to the bloodstream, in a large caliber vessel whose lumen will be least obstructed, we reason, will promote lowest substrate for DVT formation and its sequelae. A tunneled course may minimize hemorrhagic and infectious risk at the time of removal.
Materials and Methods
We have placed these catheters in patients ranging in size from neonates under 2 kg to beyond infancy. After median sternotomy and pericardotomy, the free edge of pericardium at the diaphragmatic border is identified (Figure 1) . A subcutaneous tunnel is created, and the 4.2 Fr single-lumen silastic catheter (Broviac Catheter with peel apart kit; Bard Peripheral Vascular, Inc, Tempe, Arizona) is delivered to the subxiphoid area, deep to the abdominal fascia.
The catheter is trimmed by directly measuring the length from the subxiphoid area to the inferior vena cava, plus 1.5 cm. This predicts a short intravascular course and enables the catheter tip to travel not beyond the lower right atrium. A needle with syringe is introduced and advanced under direct visualization through the subpericardial layer of the central tendon of the diaphragm, taking care to remain sufficiently superficial so as not to enter the subjacent peritoneum and liver capsule (Figures 2A and 3A , B).
Although aspirating, the needle is advanced into the right atrium at its junction with the inferior vena cava ( Figure 2B ). Once blood returns easily into the syringe, a 0.64 mm diameter J-tip guidewire is advanced into the lower right atrium (Figures 2C and 3C). A vessel dilator and peel-away sheath introducer are gently advanced as a unit over the guidewire. The vessel dilator and the guidewire are withdrawn, leaving the sheath in place. The catheter is advanced through the sheath into the lower right atrium, the sheath is peeled away, blood return and flush are demonstrated ( Figure 3D, E) . For procedures that require atriotomy, the catheter tip position is directly verified intraoperatively. Radiographic and or echocardiographic confirmation of catheter tip position is routinely made (Figure 4 ).
Comment
Percutaneous placement of central venous catheters perioperatively or postoperatively in the intensive care unit is common and is associated with complications. Insertion-related complications including arterial puncture, pneumothorax, hemothorax, cardiac tamponade, and failure of placement are known to increase line-related morbidity. 3 Stasis, turbulence, or flow disruption occurs from a CVL occupying the lumen of a vessel, with increasing effect related to the caliber of catheter and vessel, and the length of the intravascular course of the catheter. A great preponderance of venous thrombotic events in the pediatric population occur in Figure 1 . Lateral schematic depiction of the heart and pericardium, demonstrating the relationship of the inferior vena cava (IVC), the right atrium (RA), and the pericardial segment of the diaphragm, with three layers labeled: the pericardium, the diaphragmatic muscle and tendon, and the peritoneal envelope. Inset shows approach of the needle and syringe in the subpericardial area after median sternotomy. Figure 2 . Schematic depiction of line placement, by Seldinger technique, in a tunneled pathway between the layers of the pericardial aspect of the diaphragm into the right atrium (RA), at the level of the inferior vena cava (IVC). The pericardium is grasped, and a needle is introduced under direct visualization into the subpericardial layer (A). The needle enters the inferior vena cava-RA junction, and blood return confirms entry (B). A wire is passed through the needle into the RA (C), over which a peel-away sheath is passed, and subsequently the catheter.
hospitalized neonates with CVLs. 4 Catheter thrombosis is more common than clinically detected, accounts for a significant number of pulmonary and systemic embolizations, and is associated with sepsis. 5 Transthoracic intracardiac lines, placed commonly at cardiotomy, are an effective alternative for short-term access, but, as they traverse the pericardial space, have a known risk of intrapericardial bleeding at the time of removal, and data regarding its use for medium-term access are lacking. 6 At our institution, safety dictates that nontunneled transthoracic lines must be removed before discharge from the intensive care unit.
We sought to identify a catheter alternative to improve catheter longevity and potentially reduce morbidity based on four principles: (1) A tunneled course to the heart to preclude the possibility of intrapericardial bleeding at the time of removal. (2) A short intravascular course producing a smaller catheter-blood interface than a percutaneous central venous line, possibly imparting lower thrombogenicity. (3) Placement of the catheter in a large central vessel to reduce luminal obstruction and predispose less to thrombosis. (4) A subcutaneously tunneled technique that may decrease the incidence of septic complications and improve line longevity. 7 Our novel technique provides the advantages of a tunneled extravascular course, and a short intravascular course in a large vessel with insertion performed in the operating room under direct vision. Broviac catheters placed in this manner have not interfered with cannulation or exposure in the surgical field. The flexible nature of the single-lumen Broviac catheter resists kinking and breakage during insertion and removal, and the small caliber makes it amenable to tunneling in the narrow pericaridodiaphragmatic space. With placement of this catheter, we have eliminated the requirement for percutaneously placed central venous (PICC) lines for most neonates. The Broviac catheter is usually placed as the initial step following sternotomy in order to provide the cardiac anesthesiologist with adequate access prior to any direct manipulation of the heart and remains an adequate mode of access for blood draws and medication until discharge to home. The use of this technique may decrease the associated risks, cost, and discomfort of multiple PICC and intravenous (IV) lines in the postoperative period and may contribute to an improvement in patient satisfaction.
Limitations to the application of this technique include the need for median sternotomy or subxiphoid access. Though we generally restrict its use to patients undergoing a concomitant procedure via the aforementioned approach, we have placed them through a small subxiphoid incision in some noncardiac patients who presented particular venous access challenges. We have placed these lines in over 300 patients and have made them our standard of care. We are designing a prospective study of their cost, line-related reintervention rate, and patient satisfaction by comparison to a strategy of transthoracic lines, followed by PICC and IV reinterventions as needed for patients without Broviac catheters.
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